Objective Glomerulonephritis is a severe manifestation of systemic lupus erythematosus (SLE)
that is usually treated with an extended course of intravenous (IV) cyclophosphamide (…

Objective In the Euro‐Lupus Nephritis Trial (ELNT), 90 patients with lupus nephritis were
randomly assigned to a high‐dose intravenous cyclophosphamide (IV CYC) regimen (6 …

Objective: To update the follow-up of the Euro-Lupus Nephritis Trial (ELNT), a randomised
prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV) …

Background Long-term immunosuppressive treatment does not efficiently prevent relapses
of lupus nephritis (LN). This investigator-initiated randomised trial tested whether …

Objective To report the 10-year follow-up of the MAINTAIN Nephritis Trial comparing azathioprine
(AZA) and mycophenolate mofetil (MMF) as maintenance therapy of proliferative lupus …

Objective To compare the effects of methotrexate (MTX), alone or in combination with
intravenous (IV) methylprednisolone (MP) or infliximab, on magnetic resonance imaging (MRI)–…

A prospective study was undertaken to evaluate PET with 18 F-fluoride for monitoring the
response to bisphosphonates in Paget’s disease of bones. Methods: Fourteen patients with a …

OBJECTIVE:: To define the burden of hand radiological damage in systemic sclerosis (SSc)
patients, compared with a control group. METHODS:: Both hands of 167 SSc patients and …

We prospectivelyfollowed a cohort of 46 newly diagnosed cases of lupus nephritis (LN) over
a mean period of five years in order to determine the renal relapse rate, to identify potential …

Objective This pilot study was aimed at evaluating the efficacy and safety of a protocol-based
treatment strategy combining mycophenolate mofetil (MMF), intravenous (IV) …